Viva Biotech Holdings 2022 SR

The report highlights Viva Biotech's 2022 performance, focusing on its one-stop integrated drug discovery and commercial delivery services. Key achievements include a 13.1% revenue increase to RMB2,379.6 million and the completion of its new headquarters in Shanghai. The company strengthened its CRO and CDMO synergy, particularly through Langhua Pharmaceutical, which obtained an MPP license for COVID-19 drug APIs. Sustainability efforts focused on energy conservation, with a 37.55% reduction in energy consumption intensity and a B- score from CDP. The group also emphasized intellectual property protection, employee well-being, and community contribution through educational partnerships.

Company: Viva Biotech Holdings

Sector: Health Care

Country: China

Year: 2022

Type: SR

Pages: 82

Back to company

Viva Biotech Holdings

Viva Biotech Holdings 2022 ESG Report

ESG Report

The report highlights Viva Biotech's 2022 performance, focusing on its one-stop integrated drug discovery and commercial delivery services. Key achievements include a 13.1% revenue increase to RMB2,379.6 million and the completion of its new headquarters in Shanghai. The company strengthened its CRO and CDMO synergy, particularly through Langhua Pharmaceutical, which obtained an MPP license for COVID-19 drug APIs. Sustainability efforts focused on energy conservation, with a 37.55% reduction in energy consumption intensity and a B- score from CDP. The group also emphasized intellectual property protection, employee well-being, and community contribution through educational partnerships.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2022

Reporting Period

Jan 1, 2022 - Dec 31, 2022

Fiscal Year

2022

Published

Apr 21, 2023

Type

Sustainability Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Sustainable Development Goals

Other Standards

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Workplace Fatalities

Employees